the ratio of apoptotic astrocytes. Conversely, rapamycin, an autophagy inducer, along with as N-acetyl-l-cysteine, a precursor of reduced glutathione, decreased MeHg-induced toxicity and the ratio of apoptotic astrocytes. These results indicated that MeHg-induced neurotoxicity was reduced, at least in part, through the activation of autophagy. Accordingly, modulation of autophagy may offer a new avenue for attenuating MeHg-induced neurotoxicity.
Introduction
Methylmercury (MeHg) is an established toxicant with significant adverse effects on human health (Wormser et al. 2012) . It damages the nervous system in human and experimental animals (Castoldi et al. 2001; Choi 1989; Farina et al. 2011a, b; Ni et al. 2012; Sanfeliu et al. 2001) . MeHg readily crosses the blood-brain barrier and accumulates in the brain (Hong et al. 2012a, b) . Although most studies on MeHg-induced CNS damage focus on neuronal toxicity (Hong et al. 2012b; Tamm et al. 2006) , astrocytes play a key role in mediating this toxicity (Aschner et al. 2000) . MeHg preferentially accumulates in astrocytes and inhibits glutamate uptake by these cells (Aschner et al. 2000; Liu et al. 2013b; , leading to the dysregulation of excitatory amino acid homeostasis, excessive synaptic glutamate concentration, and excitotoxicity (Aschner et al. 1993; Deng et al. 2014; Liu et al. 2014 ). In addition, MeHg induces reactive oxygen species (ROS) production in neonatal rat cerebral astrocyte cultures (Dreiem and Seegal 2007; Wagner et al. 2010) and in brain slices (Wagner et al. 2010) , an effect Abstract Autophagy is an evolutionarily conserved process in which cytoplasmic proteins and organelles are degraded and recycled for reuse. There are numerous reports on the role of autophagy in cell growth and death; however, the role of autophagy in methylmercury (MeHg)-induced neurotoxicity has yet to be identified. We studied the role of autophagy in MeHg-induced neurotoxicity in astrocytes. MeHg reduced astrocytic viability in a concentration-and time-dependent manner, and induced apoptosis. Pharmacological inhibition of autophagy with 3-methyladenine or chloroquine, as well as the silencing of the autophagyrelated protein 5, increased MeHg-induced cytotoxicity and 1 3 that is reversed by treatment with antioxidants (Allen et al. , 2002 Shanker and Aschner 2003) .
Autophagy is an evolutionarily conserved catabolic pathway that is responsible for the bulk of proteolysis in normal cells, leading to the degradation of proteins and organelles, especially in stressed cells (Cherra et al. 2010; Rami 2009 ). Nevertheless, activation of the autophagic pathway above a certain threshold may result in cellular dysfunction and cell death (Aki et al. 2013; Mader et al. 2012; Shen et al. 2012) . Autophagy commences with the formation of double-membrane vesicles, referred to as autophagosomes (autophagic vacuoles in mammalian cells), that sequester cytoplasm and organelles. The autophagosomes fuse with lysosomes, forming autophagolysosomes, resulting in the degradation of their contents into basic molecules, and recycling for reusage (Cuervo et al. 2005; Essick and Sam 2010) .
Autophagy contributes to the turnover of cytoplasmic components (Cuervo et al. 2005; Larsen and Sulzer 2002) and mediates normal development and differentiation in response to environmental stimuli (Jones et al. 2013; Milisav et al. 2012) . It has been shown that excessive metal exposures can also induce autophagy both in vitro and in vivo (Chargui et al. 2011; Guo et al. 2010; Harhaji-Trajkovic et al. 2009; Yang et al. 2014) . For example, cadmium (Cd) has been shown to induce autophagy in skin epidermal cells (Son et al. 2011 ) and in vascular endothelial cells (Dong et al. 2009 ), while inorganic mercury (Hg) has been shown to induce autophagic cell death in rat hepatocytes and glioma cells (Chatterjee et al. 2012 ). In addition, oxidative stress-induced autophagy has been shown to be involved in apoptosis in vivo (Duan et al. 2013 ) and in vitro (Ranjan et al. 2014) . However, autophagic cell death appears to be independent of apoptosis in transformed cancer cells (Chen and Gibson 2008 ). The precise relationship between autophagy and apoptosis has yet therefore to be fully understood.
Here, we examine the role of autophagy in MeHginduced neurotoxicity in primary rat astrocytes and decipher its underlying toxic mechanisms, thereby identifying potential novel targets for neuroprotection against MeHg.
Materials and methods

Reagents and antibodies
For Western blot analysis, the polyclonal antibodies to LC3B, Beclin 1, P62/SQSTM1, and cleaved caspase 3 were obtained from Cell Signaling Technology (Beverly, MA, USA). β-Actin and horseradish peroxidase-conjugated secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). , chloroquine (CQ), and acridine orange (AO) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Rapamycin was purchased from Gene Operation, Inc. (Ann Arbor, MI, USA), and the Annexin V FITC/PI apoptosis detection kit was obtained from Multisciences (Hangzhou, China).
Cell culture and treatments
Primary rat astrocyte cultures were prepared as follows: The cerebral hemispheres of neonatal rats were removed, and the meninges were dissected away. The basal ganglia and midbrain were excised, and the remaining cortical tissue was dissociated with trypsin. Cells were grown in Dulbecco's modified Eagle medium (DMEM; Hyclone), supplemented with 10 % fetal bovine serum (Gibco). Cultures were maintained in an environment of 5 % CO 2 at 37 °C, with fresh medium exchanged twice weekly. Cultures were treated with MeHg after 2 weeks in vitro, when cells had reached ~95 % confluency. Astrocyte cultures used for Western blot analysis and apoptosis detection assays were grown in 6-well plates, whereas those used for cell viability and cytotoxicity assays were grown in 96-well plates. Fig. 1 Effect of MeHg on cell viability and cytotoxicity in rat primary astrocytes. Astrocytes were treated with various concentrations (1-10 μM) of MeHg for 6 h. Next, cell viability and the cytotoxicity were assessed with the MTT assay (a) and LDH detection kits (b). Statistical analysis was carried out by one-way analysis of variance (ANOVA) followed by Dunnett test. Values represent mean ± SD. *P < 0.05 compared to the control group Measurement of cell viability and cytotoxicity Primary astrocytes were treated for 6 h with MeHg at 0, 1, 2, 5, or 10 µM. These concentrations were selected based on the calculation by Shapiro and Chan (2008) and Aschner (2012) , and they are physiologically relevant to human in vivo exposures (Choi et al. 1978; Takeuchi 1985; Aschner 2012) . A lactate dehydrogenase (LDH) cytotoxicity detection kit (Nanjing Jiancheng, Nanjing, China) was used as a surrogate measure of cell death. The culture supernatant was transferred into 96-well plates, and LDH activity in the culture supernatant was analyzed. Absorbance was analyzed at 490 nm, according to the manufacturer's protocol.
Cell viability was determined by the MTT 3-(4,5-dimethylthiazol-2-yl-2,5-diphenyl-tetrazolium bromide) assay. After treatment with MeHg, MTT was added (final concentration 0.5 mg/ml) and cultures were incubated for 3 h.
Tetrazolium formed in viable cells was released by the addition of dimethyl sulfoxide, and optical density was determined with a microplate reader (BIO-TEK Instruments, Inc., Winooski, VT, USA) at 490 nm.
Assessment of apoptosis by flow cytometry
To quantify apoptotic cells, astrocytes were treated with MeHg (5 μM for 6 h), with or without pretreatment with several autophagy regulators (3-MA, CQ, rapamycin or Atg5 siRNA). Next, flow cytometric analysis was performed with the Annexin V FITC/PI apoptosis detection kit, according to the manufacturer's instructions, and analyzed by flow cytometry with BD Accuri C6 software (Becton-Dickinson, San Jose, CA, USA). Both Annexin V + /PI + cells and Annexin V + /PI − cells were considered as apoptotic cells (Fu et al. 2008) . The volume of the cellular acidic compartment, a marker of autophagy, was visualized with the lysosomotropic agent, AO (Tasdemir et al. 2008) . AO freely crosses biological membranes and accumulates in acidic compartments, where it can be visualized as bright red fluorescence. Astrocytes were treated for 6 h with MeHg (5 μM) followed by 15-min incubation with 1 μg/ml AO. The cells were washed three times with PBS before observation with a fluorescent microscope (Zeiss Axi Observer, Oberkochen, Germany).
Western blot analysis
Western blot analysis was performed as previously described. Briefly, to prepare whole-protein lysates, cells were washed three times with PBS, harvested, and lysed in a radioimmunoprecipitation assay lysis buffer, then incubated on ice for 10 min and centrifuged at 12,000g for 15 min. Protein concentration was determined with bicinchoninic acid (BCA). Equal amounts of proteins were subjected to sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE), transferred to polyvinylidene difluoride (PVDF) membranes, and incubated overnight at 4 °C with primary antibody (LC3 B, Beclin 1, p62, and β-actin). The membranes were incubated with secondary antibodies. The corresponding bands were detected using the MiniChemi Mini Size Chemiluminescent Imaging System (Beijing Sage Creation Science Co. Ltd, Beijing, China). Results were expressed as percentages of the control group.
siRNA interference
The small interfering RNAs (siRNAs) for Atg5 were designed and purchased from Guangzhou Ribobio Co., Ltd (Guangzhou, China). The sequences of the three siRNAs were as follows: (5′-GACGGATUUCCAACGUGCUU dTdT-3′ and 5′-AAGCACGUUGGAAUCCGUC dTdT-3′), (5′-GAAGGUUAUGAGACAAGAA dTdT-3′ and 5′-UUCU UGUCUCAUAACCUUC dTdT-3′), and (5′-GAGGCUCAC UUUAUGUCAU dTdT-3′ and 5′-AUGACAUAAAGUGAGC CUC dTdT-3′). Astrocytes were seeded in 24-well plates and, at ~60 % confluence, transfected with 80 nM siRNA with Lipofectamine 2000 in Opti-MEM medium (Invitrogen), according to the manufacturer's protocol. The transfected cells were cultured for an additional 48 h and validated for efficacy of silencing by Western blot analysis.
Statistical analysis
Results were expressed as mean ± SD. Statistical analysis was performed by a one-way analysis of variance (ANOVA), following appropriate transformation to normalized data and equalized variance where necessary. All assays were repeated at least three times in at least three independently derived astrocyte cultures. A P value <0.05 was considered statistically significant.
Results
Cytotoxic effects of MeHg in astrocytes
Astrocytes were treated with MeHg (0, 2, 5, or 10 µM) over various time intervals (from 3 to 24 h), followed by cell viability determination. MeHg reduced cell viability in a concentration-and time-dependent manner (Fig. 1a) . 
◂
When the cells were treated with 5 µM MeHg for 6 h, cell viability was significantly reduced compared to controls (P < 0.05). LDH release (Fig. 1b) was increased in a concentration-dependent manner and was significantly elevated compared to controls (P < 0.05) in astrocytes treated with 5 µM MeHg for 6 h.
MeHg activates apoptosis in astrocytes
To determine the MeHg-induced cell death modality, we assessed apoptosis with the Annexin V FITC/PI apoptosis detection kit. The ratio of apoptotic astrocytes induced by MeHg was significantly increased (1, 5, 10 µM) in a concentration-dependent manner (Fig. 2) . Notably, cleaved caspase-3 was also detected in these cells (Fig. 3) , consistent with MeHg-induced apoptosis.
MeHg activates autophagy in astrocytes
Next, we investigated whether autophagy could be induced in astrocytes upon treatment with MeHg. As shown in Fig. 3 , autophagosomes (red dots) were observed in MeHg-treated cells, while untreated cells showed fewer autophagosomes. The conversion of LC3-I into LC3-II and the expression of Beclin 1 showed a similar pattern (Fig. 4) , with significant increases in the expression of LC3-II and Beclin1 in response to 1 µM MeHg, and a sharp decrease in expression at 5 or 10 μM MeHg. Unexpectedly, P62, which is normally considered as the substrate of autophagy and should decrease when autophagy is activated, showed an analogous trend for increased LC3-II.
Suppression of autophagy enhances MeHg-induced cytotoxicity in astrocytes
To investigate the role of autophagy in MeHg-induced neurotoxicity, astrocytes were pretreated with 3-methyladenine (3-MA) (2 mM for 12 h) or chloroquine (CQ) (50 μM for 6 h), followed by treatment with MeHg (5 μM for 6 h). 3-MA is a class III phosphatidylinositol-3 kinase (PI3 K) inhibitor, which specifically inhibits the formation of autophagosome (Wu et al. 2013) . CQ is clinically used as an antimalarial drug, which suppresses the fusion of autophagosome with lysosomes (Palmeira-Dos-Santos et al. 2014). Cell viability was determined with the MTT assay, and autophagy markers were detected by Western blot analysis. As shown in Fig. 5 , the viability of astrocytes pretreated with 3-MA or CQ prior to MeHg treatment was significantly decreased (P < 0.05) compared to cells treated with MeHg alone. The level of LC3II and Beclin1 significantly decreased (P < 0.05) upon pretreatment with 3-MA and CQ (Fig. 6) . However, the level of the LC3-binding protein P62, a specific substrate for autophagy, was increased. In contrast to this finding, autophagy was previously reported to be accompanied by reduction in P62 levels (Larsen et al. 2010) . Notwithstanding this exception (see "Discussion" below), our findings were consistent with MeHg-induced inhibition of autophagy and increased cytotoxicity. Cleaved caspase 3, an apoptotic protein marker, showed the same trend (Fig. 6) . These results confirmed that the induction of autophagy protected astrocytes from MeHg-induced cytotoxicity (Fig. 7) . Moreover, siRNA targeting Atg5 significantly suppressed (P < 0.05) the expression of Atg5 in astrocytes (Fig. 8a) . Transfection with negative control siRNA did not affect cell viability, whereas the MeHg cytotoxicity in Atg5-silenced cells was significantly (P < 0.05) increased compared to the negative control (Fig. 8b) .
Activation of autophagy protects astrocytes from MeHg-induced cytotoxicity
Astrocytes were treated for 6 h with 5 μM MeHg after pretreatment with rapamycin (1 μM for 12 h). Rapamycin is an inhibitor of the mTOR signaling pathway and is frequently used to induce autophagy (Thoreen and Sabatini 2009) . As shown in the Fig. 6 , the conversion of LC3-I to LC3-II and the level of Beclin 1 were significantly increased upon pretreatment with rapamycin compared to astrocytes treated with MeHg alone (P < 0.05). In contrast to the results of pretreatment with 3-MA or CQ, the viability of astrocytes pretreated with rapamycin was significantly increased (P < 0.05) when compared to cells treated with MeHg alone (Fig. 9a) .
Autophagy delays apoptosis in MeHg-treated astrocytes
To determine whether MeHg-induced toxicity was accompanied by increased apoptosis, astrocytes were subjected to flow cytometry with the Annexin V FITC/PI apoptosis detection kit. As shown in Fig. 9a , upon pretreatment Fig. 7 Suppression of autophagy increases the ratio of apoptotic astrocytes. Astrocytes were treated with MeHg (5 μM for 6 h), with or without pretreatment with 3-methyladenine (3-MA) (2 mM for 12 h), chloroquine (CQ) (50 μM for 6 h). Apoptotic cells were detected with the Annexin V FITC/PI apoptosis detection kit. a Representative flow cytometry analysis of Annexin V-PI staining in MeHg-treated astrocytes with or without the pretreatment of 3-MA or CQ. Cells located in the lower right quadrant (PI negative/Annexin V positive) were designated as early apoptosis. Cells in the lower left quadrant (PI negative/Annexin V negative) were considered viable, and cells in the upper quadrants (PI positive) were considered late apoptosis or necrosis. b Quantitative analysis of flow cytometry. Results expressed as percentage of total number of cells counted. Statistical analysis was carried out by one-way ANOVA followed by Dunnett test. Data shown are representative of three independent experiments. *P < 0.05 compared with the MeHg-treated group with 3-MA or CQ, the ratio of apoptotic cells significantly increased (P < 0.05) compared to astrocytes treated with MeHg alone. The ratio of apoptotic cells in rapamycin pretreated astrocytes significantly decreased compared to astrocytes treated with MeHg alone (P < 0.05) (Fig. 9b) . These results indicate that induced autophagy attenuated apoptosis in MeHg-treated cells.
NAC attenuates cytotoxicity and autophagy in MeHg-treated astrocytes MeHg-induced cytotoxicity in astrocytes was attenuated by pretreatment with N-acetyl-l-cysteine (NAC) (5 mM for 4 h) followed by MeHg (5 µM for 6 h) treatment (Fig. 10) . Furthermore, pretreatment with NAC followed by MeHg treatment significantly (P < 0.05) decreased the level of the autophagy-related proteins, LC3, Beclin1, and P62, compared to treatment with MeHg alone (Fig. 11) . These results indicated that NAC conferred protection from MeHg-induced cytotoxicity, concomitant with a reduction in MeHg-induced autophagy.
Discussion
In this study, we tested whether MeHg could induce autophagy in rat primary astrocytes. The results establish that MeHg treatment decreases the viability of primary astrocytes in a concentration-and time-dependent manner, with induction of both autophagy and apoptosis. Unregulated autophagy protects rat primary astrocytes from MeHg-induced cell death. The MTT assay (Fig. 5) confirmed that pharmacological inhibition of autophagy with 3-MA or CQ as well as genetic inhibition of autophagy with Atg5 siRNA exacerbates MeHg's neurotoxicity, while activation of autophagy by rapamycin prevents cell death (Fig. 9) . Notably, NAC can inhibit the activation of autophagy by MeHg. These results indicate that autophagy plays an important role in MeHg-induced neurotoxicity.
This is the first study to establish the significance of MeHg-induced autophagy in the nervous system, the tissue most susceptible to this metal. Autophagy has been recognized as an essential pathway to degrade and recycle damaged proteins and/or organelles and also serves as a survival response to stress or triggering mechanisms of toxic actions (Orrenius et al. 2013; Wei et al. 2014; Zhang et al. 2012) . The fact that autophagy in neonatal rat primary astrocytes is activated by MeHg is thus not surprising. Induction of both autophagy and apoptosis by MeHg has been described in human neural stem cells via the AKT-mTOR pathway and caspase-dependent apoptosis (Chang et al. 2013 ). In addition, inorganic mercury has been shown to induce autophagy in rat hepatocytes treated in vitro (Chatterjee et al. 2012 (Chatterjee et al. , 2013 . Other metals, such as cadmium, chromium, selenium, and copper, have also been shown to induce autophagy and apoptosis (Laha et al. 2014; Pourahmad and O'Brien 2001; Wang et al. 2013; Yin et al. 2011) . Since all metals are known to reduce cellular redox via oxidative stress, the role of ROS (superoxide ion, Fig. 8 Expression of autophagy-related protein 5(Atg5). a Atg5-targeted siRNA suppresses the expression of Atg5. Astrocytes were transfected for 48 h with siRNA targeting Atg5, followed by Western blot analysis. b Interference with Atg5 significantly decreased astrocytic viability upon treatment with MeHg (5 μM for 6 h). Cell viability was determined with the MTT assay. Statistical analysis was carried out by one-way ANOVA followed by Dunnett test. *P < 0.05, compared with siRNA control group. # P < 0.05 compared with the MeHg-treated group hydrogen peroxide, and hydroxyl radical) in metal-induced autophagy warrants further exploration. NAC has been widely used as an antioxidant and a donor of sulfur group for reduced GSH production (Ballatori et al. 1998) . Our findings established that NAC attenuated MeHg-induced cytotoxicity and autophagy (Fig. 11) , corroborating that oxidative stress plays critical role in MeHg neurotoxicity (Farina et al. 2011a, b) . Inhibition of autophagy by specific autophagic inhibitors and genetic RNA interference exacerbates MeHg cytotoxicity, and in contrast, pre-induction of autophagy partially abrogates MeHg cytotoxicity in astrocytes. Thus, it may be concluded that activation of autophagy by MeHg is a pro-survival response that may be attributed to ROS overproduction. Our findings provide additional evidence for its underlying mechanisms of toxicity, suggesting that oxidative stress is a common pathway in metal ion-induced autophagy.
Autophagy and apoptosis are not mutually exclusive phenomena. The cross talk between autophagy and apoptosis reflects a complex relationship. Within the context of MeHg exposure, we find that this organometallic compound induces both autophagy (Fig. 2) and apoptosis (Fig. 4) . Inhibition of autophagy exaggerated MeHginduced toxicity. The flow cytometry results (Fig. 7) confirmed this hypothesis by demonstrating that enhanced autophagy protects astrocytes from MeHg-induced toxicity. Several previous reports showed that inhibition of apoptosis causes autophagy and inhibition of autophagy triggers apoptosis. Low concentrations of Cd induced autophagy in vascular endothelial cells, and as a consequence, apoptosis was inhibited ). Chang et al. (2011) demonstrated a significant increase in autophagy in A549 cells stably expressing elevated BECN1, concomitant with a decrease in the levels of apoptosis-related protein. The   Fig. 9 Activation of autophagy protects astrocytes from MeHginduced cytotoxicity. Astrocytes were treated with 5 μM MeHg for 6 h in the pre-presence or absence of rapamycin (1 μM for 12 h). Apoptotic cells were detected with the Annexin V FITC/PI apoptosis detection kit. Astrocytic viability was measured with the MTT assay (a). b Representative flow cytometry analysis of Annexin V-PI staining in MeHg-treated astrocytes with or without the pretreatment of rapamycin. c Quantitative analysis of flow cytometry. Results expressed as percentage of total number of cells counted. Statistical analysis was carried out by one-way ANOVA followed by Dunnett test. Data shown are representative of three independent experiments. *P < 0.05 compared with the MeHg-treated group present study suggests that MeHg-induced autophagy may delay the occurrence of apoptosis in astrocytes, consistent with previous reports on autophagy-delayed apoptosis under stress conditions (Cui et al. 2007; Kroemer and Levine 2008; Liou et al. 2014; Liu et al. 2013a; Son et al. 2011) .
We found that P62 protein levels showed a similar change to LC3II (Fig. 4) . P62 has a UBL-binding sequence (UBS) domain through which it can mediate sequestration of ubiqutinated proteins into autophagosomes (Seto et al. 2013; Zhang et al. 2013) . It is commonly degraded with the cargo, and its levels are regulated by the Nrf2 pathway (Jain et al. 2010) , the Ras/MAPK pathway (Galavotti et al. 2013) , or the JNK/c-Jun pathway (Puissant and Auberger 2010) . Though degradation of p62 serves as a marker of autophagy activation, our findings somewhat unexpectedly showed that p62 increases with the activation of autophagy. This may be due to MeHg-induced inhibition of p62 by lysosomal disruption (Daré et al. 2001; Tofighi et al. 2011) . p62 has multiple domains to regulate cellular events (Bitto et al. 2014; Wang et al. 2014 ) and may trigger nuclear factor-κB (NF-κB) activity to promote cell survival responses (Chen et al. 2014) . Thus, the significance of enhanced p62 protein by MeHg needs further study.
In summary, we demonstrate that MeHg activates prosurvival autophagy via ROS production and that induction of autophagy protects against MeHg neurotoxicity. Our findings provide a putative, novel target for therapeutic intervention to protect against MeHg-induced toxicity. Values are means ± SD. *P < 0.05 compared with the MeHg-treated group
